Skip to main content
. 2022 Aug 27;12:14632. doi: 10.1038/s41598-022-19061-3

Table 3.

Performance of metabolite biomarker panel for distinguishing patients with GC from healthy individuals in the training set, tenfold cross validation, and test set.

Training set tenfold cross validation Test set
AUC (95%CI) 0.9586 (0.9384–0.9788) 0.9438 (0.9163–0.9714) 0.9318 (0.8525–1.0000)
Sensitivity 0.8611 0.8750 0.9545
Specificity 0.9565 0.9006 0.8636

GC, gastric cancer; AUC, area under receiver operating characteristic curve.